Vaccines & Biologics
Ocrevus 300 mg/10 ml Concentrate for Solution for Infusion
Concentrate for Solution for Infusion · 300 mg/10 ml · 10 mL x 1's (in vial) · by Roche Products Limited
About This Product
What’s in It
Each vial contains 300 mg of Ocrelizumab in 10 mL at a concentration of 30 mg/mL. The final medicinal product concentration after dilution is approximately 1.2 mg/mL. Ocrelizumab is a humanised monoclonal antibody produced in Chinese Hamster Ovary cells by recombinant DNA technology